168 completed. 168 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 168 | Completed 168 |
Follow Hyperlipidemias: new trials by email Literature Review of Hyperlipidemias trials Research Report on Hyperlipidemias
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Dual vs Triple Lipid-Lowering Therapy in Type 2 Diabetes Mellitus Patients With Elevated LDL Cholesterol Rosuvastatin + Ezetimibe, Bempedoic Acid + Ezetimibe, Rosuvastatin + Ezetimibe + Bempedoic Acid - Type 2 Diabetes Mellitus, Hypercholesterolemia / Elevated LDL Cholesterol | Phase 4 | Completed | Bahria University | 126 | 2026-01-01 | 2026-10-20 |
| A Study to Investigate the Effectiveness and Safety of Bempedoic Acid in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia in Taiwan Bempedoic acid 180 mg tablet - Primary Hypercholesterolemia or Mixed Hyperlipidemia | Phase 4 | Completed | Daiichi Sankyo | 180 | 2025-04-01 | 2025-12-08 |
| A Study to Investigate LDL-cholesterol Lowering With Inclisiran Compared to Bempedoic Acid in Patients With Atherosclerotic Cardiovascular Disease. Inclisiran sodium, BPA - Hypercholesterolemia | Phase 4 | Completed | Novartis Pharmaceuticals | 402 | 2024-06-21 | 2026-07-29 |
| EMERALD (Emergency Medicine Cardiovascular Risk Assessment for Lipid Disorders) moderate- or high-intensity statin/ rosuvastatin - Lipid Disorder | Phase 4 | Completed | Wake Forest University Health Sciences | 22 | 2023-03-08 | 2026-10-02 |
| Study of Efficacy, Safety, Tolerability and Quality of Life of Inclisiran (KJX839) vs Placebo, on Top of Ongoing Individually Optimized Lipid-lowering Therapy, in Participants With Hypercholesterolemia Inclisiran Sodium, Placebo - Hypercholesterolemia | Phase 4 | Completed | Novartis Pharmaceuticals | 1770 | 2022-04-08 | 2026-04-14 |
| Lipid Management in Renal Transplant Recipients Using Evolocumab. Evolocumab - Hyperlipidemias | Phase 4 | Completed | Brigham and Women's Hospital | 81 | 2021-02-17 | 2026-04-16 |
| The Use of Icosapent Ethyl on Vascular Progenitor Cells in Individuals With Elevated Cardiovascular Risk Icosapent Ethyl 1000 MG Oral Capsule [Vascepa] - Cardiovascular Diseases, Cardiovascular Risk Factor | Phase 4 | Completed | Canadian Medical and Surgical Knowledge Translation Research Group | 70 | 2020-09-24 | 2024-04-02 |
| Effect of Pitavastatin on Bone Pitavastatin - Osteoporosis, Osteopenia, Hypercholesterolemia | Phase 4 | Completed | Seoul National University Bundang Hospital | 70 | 2019-04-08 | 2024-04-11 |
| Effect of Red Yeast Rice Beside Statin on Lipid Profile Red Yeast Rice Pill, Placebo - Hyperlipidemias | Phase 4 | Completed | Shiraz University of Medical Sciences | 92 | 2019-03-01 | 2021-10-27 |
| Expression of Pro- and Anti-inflammatory Cytokines During Anti-PCSK9 in Familial Hypercholesterolemia Evolocumab - Hypercholesterolemia, Familial | Phase 4 | Completed | Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado | 20 | 2019-01-01 | 2024-01-30 |
| Safety and Tolerability of Repatha® (Evolocumab) in Indian Participants With Homozygous Familial Hypercholesterolemia evolocumab - Homozygous Familial Hypercholesterolemia HoFH | Phase 4 | Completed | Amgen | 30 | 2018-08-04 | 2024-05-29 |
| Evaluate Efficacy and Safety of Ezetimibe/Rosuvastatin and Candesartan Cilexetil/Amlodipine Besylate Combination Tablets Ezetimibe/Rosuvastatin, Candesartan cilexetil/Amlodipine besylate, Candesartan cilexetil - Hypertension, Hyperlipidemia | Phase 4 | Completed | HK inno.N Corporation | 127 | 2018-07-05 | 2022-05-10 |
| Alirocumab and Plaque Burden In Familial Hypercholesterolaemia Alirocumab - Familial Hypercholesterolemia | Phase 4 | Completed | Fundación Hipercolesterolemia Familiar | 104 | 2018-05-01 | 2022-07-19 |
| Rosuvastatin/Ezetimibe vs Rosuvastatin in Korean Patients With Type 2 Diabetes Mellitus and Hypercholesterolemia Rosuvamibe® Tab, Monorova® Tab - Type 2 Diabetes Mellitus, Hypercholesterolemia | Phase 4 | Completed | Yuhan Corporation | 140 | 2018-02-23 | 2019-07-23 |
| Impact of Statin Therapy on Adaptations to Aerobic Exercise Lipitor 20Mg Tablet, Lipitor 80Mg Tablet, Placebo - Cardiovascular Diseases | Phase 4 | Completed | University of Kansas Medical Center | 52 | 2018-02-01 | 2025-04-15 |
| Clinical Trial to to Compare of the Efficacy and Safety of Lipilou® 20 mg and Lipilou® 10 mg Lipilou®(generic atorvastatin drug) 20 mg, Lipilou®(generic atorvastatin drug) 10 mg - Hypercholesterolemia | Phase 4 | Completed | Chong Kun Dang Pharmaceutical | 250 | 2017-10-11 | 2020-08-12 |
| A Study to Compare Rosuvastatin/Ezetimibe and Rosuvastatin in Patients With Diabetes Mellitus and Hypercholesterolemia Rosuvastatin+Ezetimibe, Rosuvastatin - Diabetes Mellitus and Hypercholesterolemia | Phase 4 | Completed | Yuhan Corporation | 85 | 2017-08-10 | 2019-09-23 |
| Lipid-lowering Therapy Individualization Atorvastatin - Hypercholesterolemia | Phase 4 | Completed | Université Catholique de Louvain | 75 | 2017-08-08 | 2019-09-03 |
| Evaluation of the Effect of a Shiitake Extract on Lipid Profile in Subjects With Moderate Hyperlipidemia Experimental product, Placebo product - Hypercholesterolemia, Hyperlipidemias | Phase 4 | Completed | Instituto de Investigación Hospital Universitario La Paz | 57 | 2017-05-08 | 2022-01-13 |
| The Effect of Omega-3 FA on Hypertriglyceridemia in Patients With T2DM(OCEAN) Omega-3 fatty acid, Placebos - Type 2 Diabetes Mellitus, Hypertriglyceridemia | Phase 4 | Completed | Shanghai Jiao Tong University School of Medicine | 309 | 2017-05-01 | 2023-10-30 |
Showing 20 of 168. Sign in to see all of them.
Hypercholesterolemia (109) · Hypertriglyceridemia (20) · Cardiovascular Diseases (17) · Dyslipidemias (17) · Insulin Resistance (12) · Hypertension (11) · Diabetes Mellitus, Type 2 (10) · Hyperlipoproteinemia Type II (10) · Atherosclerosis (9) · Coronary Disease (9) · Diabetes Mellitus (9) · Coronary Artery Disease (8) · HIV Infections (6) · Inflammation (4)
Nutritional and Metabolic Diseases (168) · Metabolic Diseases (167) · Lipid Metabolism Disorders (164) · Dyslipidemias (151) · Vascular Diseases (42) · Cardiovascular Diseases (35) · Glucose Metabolism Disorders (31) · Myocardial Ischemia (21) · Heart Diseases (20) · Arterial Occlusive Diseases (19) · Arteriosclerosis (19) · Endocrine System Diseases (19) · Hyperinsulinism (15) · Pathological Conditions, Signs and Symptoms (12)
Atorvastatin (37) · Ezetimibe (28) · Rosuvastatin Calcium (19) · Simvastatin (19) · Fenofibrate (10) · Ezetimibe, Simvastatin Drug Combination (9) · Colesevelam Hydrochloride (8) · Omacor (8) · Pravastatin (8) · pitavastatin (8) · Hydroxymethylglutaryl-CoA Reductase Inhibitors (7) · Amlodipine (6) · Niacin (5) · alirocumab (4) · evolocumab (3)
Organon and Co (16) · Pfizer's Upjohn has merged with Mylan to form Viatris Inc. (11) · Gachon University Gil Medical Center (9) · Daiichi Sankyo (7) · Seoul National University Hospital (4) · Yonsei University (4) · AstraZeneca (3) · JW Pharmaceutical (3) · GlaxoSmithKline (2) · Kumamoto University (2) · Novartis Pharmaceuticals (2) · Radiant Research (2) · Takeda (2) · UCSF Benioff Children's Hospital Oakland (2) · University Hospital Freiburg (2)
United States (44) · South Korea (27) · Japan (11) · Canada (7) · France (7) · Germany (6) · Spain (6) · China (5) · Mexico (5) · Taiwan (5) · Poland (4) · Austria (3) · Belgium (3) · Czechia (3) · Greece (3)
Ronald M Krauss, M.D. (2) · Aaron I Vinik, MD, PhD (1) · Adrian S Dobs, MD (1) · Alex Laursen, D.M., DMSc (1) · Alicja E. Grzegorzewska, MD, PhD (1) · Ana Polanco, MD (1) · Andreas Hahn, Prof. (1) · Andrew D Carr, MD (1) · Anh Le, PhD (1)
PMID 10323786, PMID 10593347, PMID 11009277, PMID 11558482, PMID 11781675, PMID 11849859, PMID 12379573, PMID 12652104, PMID 16404415, PMID 16749654, PMID 16893434, PMID 16923260, PMID 17011942, PMID 17407633, PMID 17578790, PMID 17668878, PMID 17711927, PMID 18172039, PMID 18332269, PMID 18398080, PMID 18404599, PMID 18545068, PMID 18559695, PMID 18762410, PMID 19060422, PMID 19095139, PMID 19104004, PMID 19116237, PMID 19167589, PMID 19286582, PMID 19407658, PMID 19423108, PMID 19597368, PMID 19608026, PMID 19651918, PMID 19820283, PMID 19879596, PMID 19939653, PMID 19967051, PMID 20067513, PMID 20298928, PMID 20339536, PMID 20413733, PMID 20467151, PMID 20617456, PMID 20663203, PMID 20684825, PMID 20888102, PMID 21062616, PMID 21122660
2004 (1), 2005 (1), 2015 (1), 2016 (1), K23AT002862 (1), K23HL169929 (1), R01AR071263 (1), R01DK061486 (1), R01HL075824 (1), R01MH071536 (1)